A simple, selective, precise, and stability-indicating thin-layer chromatographic method has been developed and validated for analysis of some angiotensin II receptor antagonists (AIIRAs), namely, Losartan potassium (Los-K), Irbesartan (Irb), and Candesartan cilexetil (Cand) in the bulk drug and in pharmaceutical formulations (tablets). The method was based on using TLC plates pre-coated with silica gel G 60 on aluminum sheets as stationary phase and the development system was performed using chloroform:methanol (9:1) giving well separated and compact spots for all the studied drugs (RF values 0.41–0.53). The separated spots were characterized by viewing under the UV lamp, then visualized as orange spots by spraying with Dragendorff's reagent and measured by densitometry. Under the optimum chromatographic conditions, linear relationships were obtained between response and concentrations of each studied drug with high correlation coefficients (0.9985–0.9994). Good accuracy and precision were successfully obtained for the analysis of tablets containing each drug alone or combined with diuretic drug hydrochlorothiazide (HCTZ). No interferences could be observed from the co-formulated HCTZ, commonly encountered excipients present in tablets as well as the degradation products. The results were compared successfully with reported methods and can be used as a stability-indicating assay.
[1]. M. J. Mycek 2000 Illustrated Reviews Pharmacology second edition Lippincott Williams & Wilkins Pennsylvania, USA 179–187.
[2]. B. G. Katzung 2007 Basic and Clinical Pharmacology tenth edition McGraw-Hill Singapore 159–177.
[3]. The United States Pharmacopeia 30-NF 25, American Pharmaceutical Association, Washington DC, USA, 2007, electronic version.
[4]. J. Nie M. Zhang Y. Fan Y. Wen B. Xiang Y. Feng 2005 J. Chromatogr. B 828 62–69.
[5]. C. F. Pedroso J. G. DeOliveira F. R. Campos A. G. Goncaues A. C. L. B. Trindade R. Pontarolo 2009 Chromatographia 69 201–206.
[6]. D. D. Rao N. V. Satyanarayan S. S. Sait R. Reddy K. Mukkanti 2009 Chromatographia 70 647–651.
[7]. L. Kristoffersen E. L. Oiestad M. S. Opdal M. Krogh E. Lundares A. S. Christophersen 2007 J. Chromatogr. B 850 147–160.
[8]. M. R. Bruretto Y. Conteras S. Clavijo D. Torres Y. Delgado F. Ovalles C. Ayala M. Galignanai J. M. Estela V. C. Martinm 2009 J. Pharm. Biomed. Anal. 50 194–199.
[9]. L. F. Tutunji M. F. Tutunji M. I. Alzoubi M. H. Khabbas A. I. Arida 2010 J. Pharm. Biomed. Anal. 51 985–990.
[10]. R. N. Rao S. Bopelli P. K. Mavrya 2009 Biomedical Chromatography 25 1599.
[11]. M. Zhang F. Wei J. Nie Y. Q. Feng 2006 J. Chromatogr. A 1102 294–301.
[12]. S. Hillaert W. V. Bossche 2003 J. Pharm. Biomed. Anal. 31 329–339.
[13]. I. H. I. Habib S. A. Weshahy S. Toubar M. M. A. El-Alamin 2008 Pharmaceutical Chemistry Journal 42 438–442.
[14]. I. Suslu N. Ozaltin S. Altinoz 2009 J. App. Electrochem. 39 1535–1543.
[15]. M. Ansari M. Kazemipour F. Khosroui M. Baradaran 2004 Chem. Pharm. Bull. 52 1166–1170.
[16]. M. Farouk O. Abd EL-Aziz A. Hemdanb M. Shehata 2011 J. American Sci. 7 300–312.
[17]. I. A. Darwish 2005 Anal. Chim. Acta 549 212–220.
[18]. H. E. Abdellatef 2007 Spectrochimica Acta Part A 66 1248–1254.
[19]. N. Erk 2003 Pharmazie 58 796–800.
[20]. S. A. Shah I. S. Rathod B. N. Suhagia S. S. Savale J. B. Patel 2001 J. AOAC Intern. 84 1715–1723.
[21]. K. E. MacCarthy Q. Wang E. W. Tsai E. R. Gilbat P. Dominic M. A. Brooks 1998 J. Pharm. Biomed. Anal. 17 671–677.
[22]. S. R. Sathe S. B. Bari 2007 Acta Chromatographica 19 270–278.
[23]. R. T. Sane M. Francis S. Pawar 2002 Indian Drugs 39 32–35.
[24]. M. Stolarczyk A. Maślanka J. Krzek 2008 J. Liq. Chroamatogr. Relat. Technol. 31 1892–1902.
[25]. B. H. Mehta S. B. Morge 2008 J. Planar Chromatogr.-Modern TLC 21 173–176.
[26]. A. Gumieniczek T. Ingot A. Kończak 2011 J. Planar Chromatogr.-Modern TLC 24 99–104.
[27]. N. J. Shah B. N. Suhagia R. R. Shah N. M. Patel 2007 Indian J. Pharm. Sci. 69 240–243.
[28]. A. S. Khodke L. V. Potale M. C. Damle K. G. Bothara 2010 Pharmaceutical Methods 1 39–49.
[29]. R. T. Sane M. Francis S. Pawar 2003 Indian Drugs 40 104–110.
[30]. F. A. Mohamed G. A. Saleh S. R. El-Shaboury A. H. Rageh 2008 Chromatographia 68 365–374.
[31]. International Conference On Hormonization, Topic Q2 (R1), 2005, Validation of Analytical Procedure, Text Methodology, http//www.icu.org/lob/media/media417.pdf.
[32]. L. Y. Galichet , Clark's Analysis of Drugs and Poisons, Electronic edition, Pharmaceutical Press, 2005.
[33]. International Conference on Harmonization, Topic Q1A (R2), 2003, http://www.ich.org/fileadmin/Public_Web_Site/ICH_Products/Guidelines/Quality/Q1A_R2/Step4/Q1A_R2__Guideline.pdf.